Cover Image

Guidance for industry : S1B testing for carcinogenicity of pharmaceuticals.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), International Conference on Harmonisation
Format:	Government Document Conference Proceeding eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [1997]
Subjects:	Carcinogenicity testing. Drugs > Testing.
Online Access:	https://purl.fdlp.gov/GPO/LPS113890

Similar Items

Guidance for industry : S1C(R2) dose selection for carcinogenicity studies.
Published: (2008)

Guidance for industry : statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals.
Published: (2001)

Guidance for industry : studies to evaluate the safety of residues of veterinary drugs in human food, carcinogenicity testing.
Published: (2006)

NTP technical report on the toxicology and carcinogenesis studies of AZT (CAS no. 30516-87-1) and AZT/[alpha]-interferon A/D in B6C3F1 mice (gavage studies) /
Published: (1999)

Annual report on carcinogens.
Published: (1980)

Carcinogenicity : testing, predicting, and interpreting chemical effects /
Published: (1999)

NTP technical report on the toxicology and carcinogenesis studies of transplacental AZT (CAS no. 30516-87-1) in Swiss (CD-1) mice : (in utero studies).
Published: (2006)

Summary report on the evaluation of short-term tests for carcinogens : collaborative study on in vivo tests.
Published: (1990)

Selected abstracts on short-term test systems for potential mutagens and carcinogens.
Published: (1981)

NTP report on the metabolism, toxicity, and predicted carcinogenicity of diazoaminobenzene (CAS no. 136-35-6) /
Published: (2001)

Survey of compounds which have been tested for carcinogenic activity.
Published: (1941)

NTP technical report on the toxicology and carcinogenesis studies of decalin (CAS no. 91-17-8) in F344/N rats and B6C3F₁ mice and a toxicology study of decalin in male NBR rats (inhalation studies) /
Published: (2005)

15th report on carcinogens, 2021.
Published: (2021)

NTP technical report on the toxicology and carcinogenesis studies of 2-methylimidazole (CAS no. 693-98-1) in F344/N rats B6C3F₁ mice : (feed studies) /
Published: (2003)

NTP technical report on the toxicology and carcinogenesis studies of methacrylonitrile (CAS no. 126-98-7) in F344/N rats and B6C3F1 mice (gavage studies) /
Published: (2001)

Bioassay of reserpine for possible carcinogenicity /
Published: (1980)

Bioassay of dixathion for possible carcinogenicity /
Published: (1978)

Bioassay of fluometuron for possible carcinogenicity /
Published: (1980)

Bioassay of phenol for possible carcinogenicity /
Published: (1980)

Report on carcinogens : carcinogen profiles /
Published: (2000)

Handbook of carcinogen testing /
Published: (1985)

NTP technical report on the toxicology and carcinogenesis studies of oxazepam (CAS no. 604-75-1) in Swiss-Webster and B6C3F₁ mice (feed studies) /
Published: (1993)

NTP technical report on the toxicology and carcinogenesis studies of riddelliine (CAS no. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies) /
Published: (2003)

Carcinogenic potential of rotenone : subchronic oral and peritoneal administration to rats and chronic dietary administration to syrian golden hamsters /
by: Freudenthal, R. I.
Published: (1981)

NTP technical report on the toxicology and carcinogenesis studies of benzophenone (CAS no. 119-61-9) in F344/N rats and B6C3F₁ mice : (feed studies).
Published: (2004)

NTP technical report on the toxicology and carcinogenesis studies of 2,4-hexandienal (CAS no. 142-83-6) in F344/N rats and B6C3F1 mice (gavage studies) /
Published: (2003)

Guidance for industry : S2B genotoxicity, a standard battery for genotoxicity testing of pharmaceuticals.
Published: (1997)

NTP technical report on the toxicology and carcinogenesis studies of dipropylene glycol (CAS no. 25265-71-8) in F344/N rats and B6C3F₁ mice (drinking water studies) /
Published: (2004)

Guidance for industry : stability testing, photostability testing of new veterinary drug substances and medicinal products.
Published: (1999)

NTP technical report on the toxicology and carcinogenesis studies of acrylonitrile (CAS no. 107-13-1) in B6C3F1 mice (gavage studies) /
Published: (2001)

NTP technical report on the toxicology and carcinogenesis studies of triethanolamine (CAS no. 102-71-6) in B6C3F₁ mice : (dermal study) /
Published: (2004)

Guidance for industry : S8 immunotoxicity studies for human pharmaceuticals.
Published: (2006)

Bioassay of tetrachloroethylene for possible carcinogenicity /
Published: (1977)

NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS no. 1746-01-6) in female Harlan Sprague-Dawley rats (gavage studies) /
Published: (2004)

Guidance for industry : investigating out-of-specification test results (OOS) for pharmaceutical production.
Published: (2006)

Bioassay of cinnamyl anthranilate for possible carcinogenicity /
Published: (1980)

Guidance for industry : genotoxic and carcinogenic impurities in drug substances and products, recommended approaches.
Published: (2008)

Short-term tests for chemical carcinogens /
Published: (1981)

Bioassay of a mixture of 1,2,3,6,7,8 and 1,2,3,7,8,9-hexachlorodibenzo-p-dioxins for possible carcinogenicity (dermal study) /
Published: (1980)

Bioassay of a mixture of 1,2,3,6,7,8- and 1,2,3,7,8,9-hexachlorodibenzo-p-dioxins for possible carcinogenicity (gavage study) /
Published: (1980)